EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Sitagliptin Induces Tolerogenic Human Dendritic Cells

Marija Drakul, Sergej Tomić iD, Marina Bekić iD, Dušan Mihajlović iD, Miloš Vasiljević, Sara Rakočević, Jelena Đokić, Nikola Popović iD, Dejan Bokonjić iD, Miodrag Čolić

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms242316829 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Marija Drakul und 9 weiteren Autor:innen. Beteiligte Einrichtung: Medical Faculty Foca, University of East Sarajevo, 73300 Foča, R. Srpska, Bosnia and Herzegovina. Hauptthemen laut MEDLINE: Interleukin-10, Dipeptidyl Peptidase 4. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of East Sarajevo, Medical Faculty Foča, Foča, Bosnia and Herzegovina, The Ministry of Science, Technological Development and Innovation, Republic of Serbia, Serbian Academy of Sciences and Arts.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sitagliptin, an anti-diabetic drug, is a dipeptidyl peptidase (DPP)-4/CD26 inhibitor with additional anti-inflammatory and immunomodulatory properties. In this study, we investigated for the first time the effect of sitagliptin on the differentiation and functions of human dendritic cells generated from monocytes (MoDCs) for 4 days using the standard GM-CSF/IL-4 procedure. LPS/IFN-γ treatment for an additional 24 h was used for maturation induction of MoDCs. Sitagliptin was added at the highest non-cytotoxic concentration (500 µg/mL) either at the beginning (sita 0d protocol) or after MoDC differentiation (sita 4d protocol). Sitagliptin impaired differentiation and maturation of MoDCs as judged with the lower expression of CD40, CD83, CD86, NLRP3, and HLA-DR, retention of CD14 expression, and inhibited production of IL-β, IL-12p70, IL-23, and IL-27. In contrast, the expression of CD26, tolerogenic DC markers (ILT4 and IDO1), and production of immunoregulatory cytokines (IL-10 and TGF-β) were increased. Generally, the sita 0d protocol was more efficient. Sitagliptin-treated MoDCs were poorer allostimulators of T-cells in MoDC/T-cell co-culture and inhibited Th1 and Th17 but augmented Th2 and Treg responses. Tolerogenic properties of sitagliptin-treated MoDCs were additionally confirmed by an increased frequency of CD4+CD25+CD127- FoxP3+ Tregs and Tr1 cells (CD4+IL-10+FoxP3-) in MoDC/T-cell co-culture. The differentiation of IL-10+ and TGF-β+ Tregs depended on the sitagliptin protocol used. A Western blot analysis showed that sitagliptin inhibited p65 expression of NF-kB and p38MAPK during the maturation of MoDCs. In conclusion, sitagliptin induces differentiation of tolerogenic DCs, and the effect is important when considering sitagliptin for treating autoimmune diseases and allotransplant rejection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Interleukin-10Dipeptidyl Peptidase 4HumansSitagliptin PhosphateCells, CulturedCell DifferentiationMonocytesTransforming Growth Factor betaDendritic CellsForkhead Transcription Factors

Stichwörter der Autor:innen

CD26 expressiondendritic cellsdipeptidyl peptidase 4 inhibitorsregulatory T cellstolerance

Substanzen

Interleukin-10Dipeptidyl Peptidase 4Sitagliptin PhosphateTransforming Growth Factor betaForkhead Transcription Factors

Autor:innen und Institutionen

  • Medical Faculty Foca, University of East Sarajevo, 73300 Foča, R. Srpska, Bosnia and Herzegovina.
  • Institute for the Application of Nuclear Energy, University of Belgrade, 11000 Belgrade, Serbia.
  • Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, 11000 Belgrade, Serbia.
  • Serbian Academy of Sciences and Arts, 11000 Belgrade, Serbia.

ORCID-Profile: Sergej Tomić, Marina Bekić, Dušan Mihajlović, Nikola Popović, Dejan Bokonjić

Förderung

  • University of East Sarajevo, Medical Faculty Foča, Foča, Bosnia and Herzegovina
  • The Ministry of Science, Technological Development and Innovation, Republic of Serbia
  • Serbian Academy of Sciences and Arts
  • Ministry of Science, Technological Development and Innovation, Republic of Serbia

Zitieren

APA

Drakul, M., Tomić, S., Bekić, M., Mihajlović, D., Vasiljević, M., Rakočević, S., Đokić, J., Popović, N., Bokonjić, D., & Čolić, M. (2023). Sitagliptin Induces Tolerogenic Human Dendritic Cells. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms242316829

Vancouver

Drakul M, Tomić S, Bekić M, Mihajlović D, Vasiljević M, Rakočević S, et al. Sitagliptin Induces Tolerogenic Human Dendritic Cells. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms242316829

BibTeX
@article{Drakul2023,
  author = {Drakul, Marija and Tomić, Sergej and Bekić, Marina and Mihajlović, Dušan and Vasiljević, Miloš and Rakočević, Sara and Đokić, Jelena and Popović, Nikola and Bokonjić, Dejan and Čolić, Miodrag},
  title = {Sitagliptin Induces Tolerogenic Human Dendritic Cells},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms242316829}
}
Kostenlos starten →